Corrigendum to “Efficacy + safety of palbociclib (P) in patients (pts) ≤50 y with hormone receptor‒positive (HR+)/human epidermal growth factor receptor 2‒negative (HER2–) advanced breast cancer (ABC): Subgroup analysis of 2 randomized phase 3 studies” [Breast 41S1 (2018) S11–12]

Saved in:

Bibliographic Details
Published in:	Breast
Main Authors:	Cristofanilli, Massimo, Harbeck, Nadia, Rugo, Hope S., Castrellon, Aurelio, Joy, Anil Abraham, Verma, Sunil, Im, Seock-Ah, Iyer, Shrividya, Puyana Theall, Kathy, Gauthier, Eric, Huang, Xin, Bartlett, Cynthia Huang, Loibl, Sibylle, Finn, Richard S.
Format:	Artigo
Language:	Inglês
Published:	Elsevier 2019
Subjects:	Corrigendum
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7375617/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2019.11.010
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items